Shandong Jincheng Pharmaceutical Group Co., Ltd
300233.SZ · SHZ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | CN¥207,735 | CN¥193,311 | CN¥285,874 | CN¥123,084 |
| Dep. & Amort. | CN¥319,261 | CN¥311,663 | CN¥258,776 | CN¥233,488 |
| Deferred Tax | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Stock-Based Comp. | CN¥0 | CN¥0 | CN¥0 | CN¥0 |
| Change in WC | -CN¥280,802 | CN¥120,722 | -CN¥495,634 | -CN¥3,723 |
| Other Non-Cash | CN¥50,392 | CN¥38,379 | CN¥91,149 | CN¥99,436 |
| Operating Cash Flow | CN¥296,586 | CN¥664,075 | CN¥255,627 | CN¥437,185 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -CN¥142,614 | -CN¥342,899 | -CN¥373,668 | -CN¥376,145 |
| Net Acquisitions | CN¥0 | CN¥0 | CN¥6,478 | CN¥6,205 |
| Inv. Purchases | -CN¥4,000 | -CN¥5,000 | -CN¥15,000 | -CN¥7,800 |
| Inv. Sales/Matur. | CN¥323 | CN¥2,292 | CN¥4,800 | CN¥150,401 |
| Other Inv. Act. | CN¥61,975 | CN¥35,618 | CN¥19,567 | -CN¥4,204 |
| Investing Cash Flow | -CN¥84,316 | -CN¥309,989 | -CN¥357,824 | -CN¥231,543 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -CN¥41,783 | -CN¥100,660 | CN¥61,129 | -CN¥1,418 |
| Stock Issued | CN¥0 | CN¥0 | CN¥56,936 | CN¥0 |
| Stock Repurch. | -CN¥55,009 | CN¥0 | -CN¥56,936 | -CN¥80,008 |
| Dividends Paid | -CN¥131,671 | -CN¥83,520 | -CN¥104,776 | -CN¥105,191 |
| Other Fin. Act. | -CN¥15,308 | -CN¥59,132 | CN¥47,476 | -CN¥32,753 |
| Financing Cash Flow | -CN¥243,771 | -CN¥243,311 | CN¥3,829 | -CN¥191,660 |
| Forex Effect | CN¥5,964 | CN¥3,466 | CN¥4,300 | -CN¥4,971 |
| Net Chg. in Cash | -CN¥25,537 | CN¥114,242 | -CN¥94,068 | CN¥9,011 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | CN¥904,021 | CN¥789,779 | CN¥883,847 | CN¥874,836 |
| End Cash | CN¥878,484 | CN¥904,021 | CN¥789,779 | CN¥883,847 |
| Free Cash Flow | CN¥153,972 | CN¥321,176 | -CN¥118,042 | CN¥61,041 |